MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
December 19, 2009
Tim Hanson
Now Is the Time to Buy Risk Emerging-market stocks have been among the most popular asset classes with investors this year. But that's why you need careful research and stock selection. mark for My Articles similar articles
The Motley Fool
February 5, 2010
Tim Hanson
The Stocks You Need to Buy Now Do you know what you're missing? With an asset allocation plan and additional foreign exposure, your portfolio will be better positioned to profit over the next decade. mark for My Articles similar articles
The Motley Fool
October 7, 2010
Tim Hanson
Where the Bargains Are Now Savvy international investors may want to reconsider where they're looking for ideas. mark for My Articles similar articles
The Motley Fool
November 21, 2007
Brian Orelli
Black Friday Bargain Stock: Dr. Reddy's Laboratories Is Dr. Reddy's Laboratories a good value right now? Growth is slowing at the generic drugmaker, but is it enough to justify the drop in price? mark for My Articles similar articles
The Motley Fool
January 7, 2010
Tim Hanson
How to Make More in 2010 2010 is shaping up to be another good year for emerging markets investors. mark for My Articles similar articles
The Motley Fool
January 11, 2010
Jennifer Schonberger
10 Predictions for the Next Decade BlackRock's Bob Doll shares his outlook for the market's next 10 years. mark for My Articles similar articles
The Motley Fool
November 12, 2009
Tim Hanson
Everybody Is Buying These Stocks When investors are all investing in the same asset, they're all just going to end up with a pretty lousy investment. So what should you do? mark for My Articles similar articles
BusinessWeek
January 31, 2005
A Fixed-Income Fund with a Twist Bill Eigen of Fidelity Strategic Income says a broadly diversified focus and careful risk management help his fund outperform mark for My Articles similar articles
The Motley Fool
February 9, 2010
Tim Hanson
How to Make More in 2010 It could have been so much better. 2010 is shaping up to be another good year for emerging-markets investors, and you'll do better in 2010 if you add global exposure to your portfolio today. mark for My Articles similar articles
The Motley Fool
February 19, 2008
Bill Mann
Why You Must Own International Stocks As a group, international stocks are no more risky than U.S. stocks. In fact, they may be less risky. mark for My Articles similar articles
The Motley Fool
March 26, 2010
Jordan DiPietro
This Number Could Double in 5 Years It's not too late to get in on emerging markets -- the absolute number of investors is still small. mark for My Articles similar articles
The Motley Fool
June 1, 2009
Dan Caplinger
Profit From the Next Big Bubble Investors are fleeing back to foreign lands. mark for My Articles similar articles
The Motley Fool
January 28, 2008
Brian Orelli
Dr. Reddy's Rough Quarter Dr. Reddy's Laboratories moves manufacturing back to India and moves forward with OTC generic drugs. mark for My Articles similar articles
The Motley Fool
July 22, 2008
Brian Orelli
The Growth Doctor Is In Dr. Reddy's grows the top line, but it still has some work to do. mark for My Articles similar articles
The Motley Fool
June 15, 2009
Brian Orelli
Strange Bedfellows GlaxoSmithKline is teaming up with none other than its arch-nemesis, generic-drug maker Dr. Reddy's Laboratories, licensing more than 100 of their brands to sell in emerging markets. mark for My Articles similar articles
BusinessWeek
November 10, 2003
Laura Cohn
These Bourses May Be Too Darn Hot Investors pondering a leap into emerging markets should proceed with caution. mark for My Articles similar articles
Financial Planning
May 1, 2007
David A. Twibell
Bonds Away Despite their checkered past, emerging market bond funds have attracted record capital inflows and rewarded investors with stellar returns. mark for My Articles similar articles
The Motley Fool
February 11, 2010
Tim Hanson
Only an Idiot Would Buy This Today As uncertainty spikes, investors seeking peace of mind should flock to lower-risk or even risk-free assets such as Treasuries. But don't do it. mark for My Articles similar articles
The Motley Fool
June 23, 2010
Jennifer Schonberger
A BlackRock Chief Investment Officer on Where to Invest Now He recommends dollar-cost averaging and some cyclicals. mark for My Articles similar articles
The Motley Fool
May 20, 2010
Jordan DiPietro
This Number Could Double in 5 Years It's not too late to get in on emerging markets -- the absolute number of investors is still small. mark for My Articles similar articles
The Motley Fool
January 23, 2007
Brian Lawler
No Generic Profit for Reddy Investors looking to hedge a pharmaceutical position in case of adverse congressional legislation (or those looking for an international company in booming India) might do well to look at Dr. Reddy's. mark for My Articles similar articles
The Motley Fool
January 7, 2008
Rex Moore
If You Do Just One Thing Today To start to plan for your retirement, whether it is just around the corner or decades away, take the first step on the road to proper asset allocation. mark for My Articles similar articles
The Motley Fool
February 8, 2011
Amanda B. Kish
Are Emerging Markets in Danger? Time will tell whether the current blip in emerging markets' fortunes is temporary or the start of a more pervasive downward trend. mark for My Articles similar articles
Financial Planning
September 1, 2009
Geoff Considine
Not Without Risk Any discussion of whether the theoretical constructs of asset allocation and diversification broke down must start with a reasonable estimate of what they were supposed to provide. mark for My Articles similar articles
The Motley Fool
March 3, 2009
Nate Weisshaar
Invest Defensively: Look Abroad Invest like your favorite blue chips. mark for My Articles similar articles
On Wall Street
October 1, 2008
Tim Knepp
Question Assumptions It's time to ask ourselves whether the blunt tools of broad asset class definitions and traditional asset allocations provide an adequate defense against the complex risk and interaction of today's markets. mark for My Articles similar articles
The Motley Fool
March 24, 2004
Bill Mann
Reddy or Not Dr. Reddy's is an Indian company with a booming business in pharmaceutical ingredient development and branded medications that it sells throughout the developing world. mark for My Articles similar articles
The Motley Fool
August 12, 2010
Tim Hanson
These ETFs Are Dangerous Buying into a single country could burn you. mark for My Articles similar articles
The Motley Fool
April 4, 2008
Brian Richards
The Investing Phenomenon You Ought to Know by Now Are you invested in equities based outside the U.S. of A.? Well, you should be. mark for My Articles similar articles
The Motley Fool
June 5, 2006
Stephen D. Simpson
Reddy More Steady? Despite sharp sell-offs in India, Dr. Reddy's is still improving. As is often the case with turnarounds, the Indian pharmaceutical doesn't look especially cheap today. mark for My Articles similar articles
The Motley Fool
September 23, 2010
Morgan Housel
Bond Bubbles? You tell us. Investors are plowing into bonds with abandon. mark for My Articles similar articles
The Motley Fool
November 20, 2008
Tim Hanson & Nate Weisshaar
How the Emerging World Will Avoid Recession Weekly news from the emerging markets of China, India, and Mexico. mark for My Articles similar articles
The Motley Fool
August 19, 2009
John Rosevear
The Boring Old Trick That Makes You Money "Diversification" may make your eyes glaze over, but it's a proven winner. mark for My Articles similar articles
Financial Planning
July 1, 2007
Peter Schiff
Liquidity Myths The one-way flow of dollars into global markets is creating worldwide asset bubbles. Will your clients be ready when those bubbles burst? mark for My Articles similar articles
The Motley Fool
April 20, 2009
Kristin Graham
The Rally Isn't Done for Good So far, we've seen an impressive rally in the markets. Yet one long-time money manager sees the potential for another 15-20% in gains even from the recent highs. mark for My Articles similar articles
BusinessWeek
April 7, 2011
Tom Keene
Tom Keene Talks to Bhanu Baweja The UBS emerging-markets currency specialist holds forth on a high-return, though politically high-risk, sector mark for My Articles similar articles
The Motley Fool
November 18, 2009
Dan Caplinger
What the New Carry Trade Means for You The hot money's doing it. Should you? What the heck is a carry trade? mark for My Articles similar articles
The Motley Fool
February 18, 2009
Ivan Martchev
3 Stock Ideas From an Emerging Powerhouse India's been hammered in the past year, but stocks are starting to look appealing again. Take a look at: Dr. Reddy's Laboratories... HDFC Bank... ICICI Bank... mark for My Articles similar articles
Finance & Development
June 1, 2000
Mohamed A. El-Erian
Where Are Emerging Markets Headed? The emerging markets look very different in early 2000. Growth is picking up in most economies, with countries like Brazil also making remarkable financial recoveries and Mexico just being upgraded by Moody's to the much-coveted investment rating. mark for My Articles similar articles
Financial Advisor
December 2009
James Picerno
The First Step There are no easy answers for asset allocation, but at least there's a practical starting point. mark for My Articles similar articles
Financial Planning
December 1, 2008
Donald Jay Korn
Submerging Markets Does it make sense to put money into emerging-markets stocks or funds now, at the current depressed prices? mark for My Articles similar articles
The Motley Fool
October 30, 2009
2 Stocks Hitting High Notes These stocks are reaching for the stars and hitting 52-week highs: Dr. Reddy's Laboratories... HMS Holdings Corp... mark for My Articles similar articles
Financial Advisor
December 2003
Lynn O'Shaughnessy
The Sleeper That Soared To the surprise of many, emerging-market debt has performed well. mark for My Articles similar articles
BusinessWeek
February 27, 2006
Einhorn & Kripalani
In India, Selling Generics Used To Be So Easy Suddenly, Indian drugmakers Dr. Reddy's and Ranbaxy have a host of copycat rivals. mark for My Articles similar articles
The Motley Fool
July 1, 2010
Jordan DiPietro
This Number Could Double in 5 Years It's not too late to get in on emerging markets -- the absolute number of investors is still small. mark for My Articles similar articles
The Motley Fool
September 9, 2010
Andrew Bond
Invest in India for Fast Growth Consider these strong Indian companies for your portfolio. mark for My Articles similar articles
AskMen.com
Scott Carter
BRIC Investing: India In this four-part installment we look at India, which rides a wave of success from three primary sectors: information technology, pharmaceuticals and financial services. mark for My Articles similar articles
The Motley Fool
June 12, 2007
Rex Moore
If You Do Just One Thing Today Take the first step on the road to proper asset allocation. You should determine your risk profile and see if your allocation is aligned with it. mark for My Articles similar articles
Investment Advisor
September 2010
Savita Iyer-Ahrestani
Overlooked Managers: Two Guys With Two Goals For Sierra Investment Management, understanding risk inherent in every asset class has enabled it to outperform, while avoiding the worst disasters in financial market history. mark for My Articles similar articles
The Motley Fool
March 24, 2008
Sham Gad
An Introduction to Asset Management Some pointers to help you choose the right path for your investments. mark for My Articles similar articles